What each framework actually does
BANT and MEDDIC are not two ways of doing the same thing. They operate at different stages of a deal and answer different questions entirely, so treating them as interchangeable options in the same debate is a reliable way to pick the wrong one.
BANT, which IBM developed in the 1950s and which has shown a rather stubborn refusal to go away, covers four things: Budget, Authority, Need, and Timeline. It’s a quick triage filter. The question it’s really answering is whether a lead is worth your time at all, and you can usually work that out in a single discovery call. It was never designed to close complex deals, just to stop you chasing ones that had no realistic chance from the start.
MEDDIC goes considerably further. It stands for Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain, and Champion, and where BANT gives you a yes/no on whether to proceed, MEDDIC maps the entire buying landscape: who controls the budget, how the decision actually gets made, who inside the organisation is championing you, and what measurable outcome the prospect is trying to achieve. It’s less a checklist than a working model of the deal.
The honest case for BANT
BANT gets a lot of criticism from people who’ve tried to use it on enterprise deals it was never meant for, which is a bit like complaining that a penknife doesn’t fell trees. For high-volume inbound pipelines, shorter sales cycles, and transactional B2B deals where one person can say yes, it’s still genuinely useful. It’s also easy to teach, and that matters more than it sounds: a framework your whole team applies consistently beats a sophisticated one that only your best reps actually use.
The limitation is real, though. BANT assumes a single decision-maker with clear authority, and that assumption breaks down almost immediately in any deal involving procurement, a buying committee, or a contract worth talking about. If you’re working a six-month enterprise cycle and asking only four questions, you don’t have a qualification process. You have a polite conversation.
When MEDDIC earns its complexity
The extra weight of MEDDIC pays for itself by surfacing the things that kill large deals late, which is always the worst time for them to die. A champion who turned out to have no real influence when the contract reached procurement. An economic buyer nobody had actually spoken to. Decision criteria that shifted halfway through because a new stakeholder joined the committee. MEDDIC forces you to confront these gaps early, when you can still do something about them.
Teams that use it rigorously also tend to produce more honest forecasts, because “70% confident” stops meaning “I have a good feeling about this one” and starts meaning something concrete: the pain is articulated, the economic buyer is identified, the champion is genuinely engaged. That’s a different kind of certainty.
Which one to use
Most teams don’t actually need to choose one and abandon the other. The sensible approach is staged: use BANT early as a lightweight filter to decide whether a lead clears the basic bar, then shift to MEDDIC as the deal grows in size, complexity, and the number of people who have to say yes before anything gets signed. Your qualification standard should rise in proportion to what the deal is going to cost you to pursue.
If your deals are mostly under £30,000 with one or two stakeholders and a short cycle, BANT is probably sufficient and MEDDIC would be overkill that slows you down without adding much. If you’re selling enterprise software with nine-month cycles and a procurement team in the mix, BANT alone will leave you with a pipeline full of deals that feel promising right up until they don’t.
And whichever framework you use, the one thing to avoid is picking it because it sounds more impressive, then quietly abandoning it when the questions get uncomfortable. A qualification framework only works if you’re actually willing to disqualify people with it.